Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID‐19 patients at risk of Covid‐associated pulmonary aspergillosis-Reference-Cited by-同舟云学术

Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID‐19 patients at risk of Covid‐associated pulmonary aspergillosis

Published:2021-08-25 Issue: Volume: Page:
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Mian Paola¹^ORCID,Trof Ronald J.²,Beishuizen Albertus²,Masselink Joost B.¹,Cornet Alexander D.²,Sportel Esther T.¹

Affiliation:

1. Department of Clinical Pharmacy Medisch Spectrum Twente Enschede the Netherlands

2. Intensive Care Center Medisch Spectrum Twente Enschede the Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13518

Reference9 articles.

1. A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients

2. EMA.Noxafil 2020. [updated 09/20/2020].2020. Available from:https://www.EMA.europa.eu/en/medicines/human/EPAR/noxafil. Accessed 4th April 2021.

3. Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

4. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

5. A national strategy to diagnose COVID‐19 associated invasive fungal disease in the ICU;White PL;Clin Infect Dis,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit;Infection;2024-03-26

2. Posaconazole exposure in critically ill ICU patients: a need for action;Infection;2023-07-27

3. The battle against fungi: lessons in antifungal stewardship from COVID 19 times;International Journal of Antimicrobial Agents;2023-07

4. Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis;Antibiotics;2022-11-26